Viveve Medical (VIVE)
OTHER OTC:VIVE
US Market

Viveve Medical (VIVE) Stock Price & Analysis

512 Followers

VIVE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $1.00
Previous Close$0.03
Volume40.81K
Average Volume (3M)N/A
Market Cap
$36.46K
Enterprise Value-$242.54K
Total Cash (Recent Filing)$5.91M
Total Debt (Recent Filing)$5.63M
Price to Earnings (P/E)>-0.1
Beta12.43
Nov 09, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.65
Shares Outstanding10,723,857
10 Day Avg. Volume480
30 Day Avg. VolumeN/A
Standard Deviation0.26
R-Squared0.00010
Alpha-0.15
Financial Highlights & Ratios
Price to Book (P/B)0.02
Price to Sales (P/S)0.02
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.04
Enterprise Value/Gross Profit-0.39
Enterprise Value/Ebitda0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

VIVE FAQ

What was Viveve Medical’s price range in the past 12 months?
Viveve Medical lowest stock price was $0.00 and its highest was $1.00 in the past 12 months.
    What is Viveve Medical’s market cap?
    Currently, no data Available
    When is Viveve Medical’s upcoming earnings report date?
    Viveve Medical’s upcoming earnings report date is Nov 09, 2023 which is in 21 days.
      How were Viveve Medical’s earnings last quarter?
      Currently, no data Available
      Is Viveve Medical overvalued?
      According to Wall Street analysts Viveve Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Viveve Medical pay dividends?
        Viveve Medical does not currently pay dividends.
        What is Viveve Medical’s EPS estimate?
        Viveve Medical’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Viveve Medical have?
        Viveve Medical has 10,723,857 shares outstanding.
          What happened to Viveve Medical’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Viveve Medical?
          Currently, no hedge funds are holding shares in VIVE

          ---

          Viveve Medical Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10
          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          Viveve Medical

          Viveve Medical, Inc. engages in the provision of health products. Its activities include development and distribution of women's health solutions. Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The company was founded on March 3, 1987 and is headquartered Englewood, CO.

          ---

          Forecast EPS vs Actual EPS

          Currently, no data available
          Please return soon. This page is being updated.

          Similar Stocks
          Company
          Price & Change
          Follow
          Medtronic
          Abbott Labs
          Baxter International
          Hologic

          Popular Stocks

          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis